These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23384962)

  • 1. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect.
    Hanley GE; Brain U; Oberlander TF
    Early Hum Dev; 2013 Aug; 89(8):519-24. PubMed ID: 23384962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception.
    Weikum WM; Oberlander TF; Hensch TK; Werker JF
    Proc Natl Acad Sci U S A; 2012 Oct; 109 Suppl 2(Suppl 2):17221-7. PubMed ID: 23045665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors.
    Smith MV; Sung A; Shah B; Mayes L; Klein DS; Yonkers KA
    Early Hum Dev; 2013 Feb; 89(2):81-6. PubMed ID: 22999988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
    Weikum WM; Mayes LC; Grunau RE; Brain U; Oberlander TF
    Infant Behav Dev; 2013 Dec; 36(4):485-93. PubMed ID: 23728194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.
    Santucci AK; Singer LT; Wisniewski SR; Luther JF; Eng HF; Dills JL; Sit DK; Hanusa BH; Wisner KL
    J Clin Psychiatry; 2014 Oct; 75(10):1088-95. PubMed ID: 25373117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mother-infant antidepressant concentrations, maternal depression, and perinatal events.
    Sit D; Perel JM; Wisniewski SR; Helsel JC; Luther JF; Wisner KL
    J Clin Psychiatry; 2011 Jul; 72(7):994-1001. PubMed ID: 21824458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant neurodevelopment following in utero exposure to antidepressant medication.
    Austin MP; Karatas JC; Mishra P; Christl B; Kennedy D; Oei J
    Acta Paediatr; 2013 Nov; 102(11):1054-9. PubMed ID: 23927695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk?
    Hanley GE; Oberlander TF
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):651-9. PubMed ID: 22733632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study.
    van der Veere CN; de Vries NKS; van Braeckel KNJA; Bos AF
    Early Hum Dev; 2020 Aug; 147():105075. PubMed ID: 32504880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study.
    Peng M; Gao K; Ding Y; Ou J; Calabrese JR; Wu R; Zhao J
    Psychopharmacology (Berl); 2013 Aug; 228(4):577-84. PubMed ID: 23559219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.
    Gurnot C; Martin-Subero I; Mah SM; Weikum W; Goodman SJ; Brain U; Werker JF; Kobor MS; Esteller M; Oberlander TF; Hensch TK
    Epigenetics; 2015; 10(5):361-72. PubMed ID: 25891251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-exposed infants and developmental outcome: effects of a home intervention and ongoing maternal drug use.
    Schuler ME; Nair P; Kettinger L
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):133-8. PubMed ID: 12580681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
    Casper RC; Fleisher BE; Lee-Ancajas JC; Gilles A; Gaylor E; DeBattista A; Hoyme HE
    J Pediatr; 2003 Apr; 142(4):402-8. PubMed ID: 12712058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior.
    Hanley GE; Brain U; Oberlander TF
    Pediatr Res; 2015 Aug; 78(2):174-80. PubMed ID: 25897539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal serotonin reuptake inhibitor antidepressant exposure, SLC6A4 genetic variations, and cortisol activity in 6-year-old children of depressed mothers: A cohort study.
    Zusman EZ; Chau CMY; Bone JN; Hookenson K; Brain U; Glier MB; Grunau RE; Weinberg J; Devlin AM; Oberlander TF
    Dev Psychobiol; 2023 Nov; 65(7):e22425. PubMed ID: 37860904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.